TRI-RT3

TRI-RT3 — The Metabolic Peptide

• Supports weight reduction
• Supports glycaemic control
• Reduces hepatic fat

Overview

TRI-RT3 is a triple agonist — it acts on the GLP-1, GIP and glucagon receptors simultaneously, where earlier compounds in its class targeted one or two. It is supplied as a lyophilised powder in a sealed vial for laboratory and in-vitro research.

PepSource supplies TRI-RT3 in 20mg and 40mg vials. Every batch is independently third-party tested for HPLC purity and mass-spectrometry identity, and the certificate of analysis for the batch you receive is published on our lab results page.

Key Specifications

• Product format: Lyophilised powder, sealed vial
• Available sizes: 20mg and 40mg vials
• Sequence / origin: Synthetic triple agonist of the GLP-1, GIP and glucagon receptors
• Purity: Verified by HPLC on every batch — the measured figure for your lot is published on its certificate of analysis
• Storage: Store sealed vials cool, dry and away from light; freeze for long-term storage
• Reconstitution: RECON-X — see our reconstitution guide
• Intended use: Laboratory research use only

Research Focus

TRI-RT3 is one of the most actively researched compounds in metabolic medicine. Published Phase 2 trial results have examined body-weight reduction, glycaemic control and hepatic fat content, with the triple-receptor mechanism reported to produce greater effect than single or dual agonists. Phase 3 trials are ongoing.

Testing & Certificates of Analysis

Each batch is tested by an independent analytical laboratory for HPLC purity and mass-spectrometry identity before release. Certificates are published per batch and searchable by lot code on our lab results page — you can verify the exact vial you were sent.

For laboratory research use only. All products sold by PepSource are strictly for laboratory research purposes and are not intended for human or veterinary consumption. No dosing, administration or physiological guidance is provided.